Daclatasvir and asunaprevir improves health‐related quality of life in Japanese patients infected with hepatitis C virus

AIMS: Interferon‐free direct‐acting antiviral agent (DAA) regimens for chronic hepatitis C virus (HCV) patients have improved their health‐related quality of life (HRQOL). Currently, there are no published data assessing the impact of DAAs regimens without sofosbuvir on HRQOL. The aim of this study...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:JGH Open
Main Authors: Ikeda, Hiroki, Watanabe, Tsunamasa, Matsumoto, Nobuyuki, Hiraishi, Tetsuya, Nakano, Hiroyasu, Noguchi, Yohei, Hattori, Nobuhiro, Shigefuku, Ryuta, Yamashita, Masaki, Nakahara, Kazunari, Matsunaga, Kotaro, Okuse, Chiaki, Yotsuyanagi, Hiroshi, Tanaka, Atsushi, Suzuki, Michihiro, Itoh, Fumio
Formato: Artigo
Idioma:Inglês
Publicado: Wiley Publishing Asia Pty Ltd 2018
Assuntos:
Original Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6207024/
https://ncbi.nlm.nih.gov/pubmed/30483569
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jgh3.12052
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares